ReviewNature reviews. Rheumatology2024
TYK2: an emerging therapeutic target in rheumatic disease.
Eric Morand et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papertrialcites it
ReviewNature reviews. Rheumatology2024
Eric Morand et al.PubMed ↗Publisher ↗
No numbers read from the abstract.